<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Urologiia</journal-id><journal-title-group><journal-title xml:lang="en">Urologiia</journal-title><trans-title-group xml:lang="ru"><trans-title>Урология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1728-2985</issn><issn publication-format="electronic">2414-9020</issn><publisher><publisher-name xml:lang="en">Bionika Media</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">296468</article-id><article-id pub-id-type="doi">10.18565/urology.2019.16.114-118</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">A role of fructose in urinary stone formation</article-title><trans-title-group xml:lang="ru"><trans-title>Роль фруктозы в генезе нефролитиаза</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Pavlova</surname><given-names>Z. Sh</given-names></name><name xml:lang="ru"><surname>Павлова</surname><given-names>З. Ш</given-names></name></name-alternatives><bio xml:lang="en"><p>Ph.D</p></bio><bio xml:lang="ru"><p>к.м.н</p></bio><email>zukhra73@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Golodnikov</surname><given-names>I. I</given-names></name><name xml:lang="ru"><surname>Голодников</surname><given-names>И. И</given-names></name></name-alternatives><bio xml:lang="en"><p>Faculty of Fundamental Medicine; Head of the Department of Urology and Andrology, Faculty of Fundamental Medicine</p></bio><bio xml:lang="ru"><p>факультет фундаментальной медицины</p></bio><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kamalov</surname><given-names>A. A.</given-names></name><name xml:lang="ru"><surname>Камалов</surname><given-names>А. А</given-names></name></name-alternatives><bio xml:lang="en"><p>Academician of the RAS, MD, professor, Director</p></bio><bio xml:lang="ru"><p>академик РАН, д.м.н., профессор, директор; заведующий кафедрой урологии и андрологии факультета фундаментальной медицины</p></bio><email>armais.kamalov@rambler.ru</email><xref ref-type="aff" rid="aff4"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Nizov</surname><given-names>A. N</given-names></name><name xml:lang="ru"><surname>Низов</surname><given-names>А. Н</given-names></name></name-alternatives><bio xml:lang="en"><p>urologist; Ph.D. student of the Faculty of Fundamental Medicine</p></bio><bio xml:lang="ru"><p>врач-уролог; аспирант факультета фундаментальной медицины</p></bio><email>nizovale@gmail.com</email><xref ref-type="aff" rid="aff5"/><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Medical Scientific and Educational Center of Lomonosov Moscow State University</institution></aff><aff><institution xml:lang="ru">Медицинский научно-образовательный центр МГУ им. М.В. Ломоносова</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Moscow State University by Lomonosov</institution></aff><aff><institution xml:lang="ru">МГУ им. М.В. Ломоносова</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Moscow State University by Lomonosov</institution></aff><aff><institution xml:lang="ru">Медицинский научно-образовательный центр МГУ им. М.В. Ломоносова</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">Medical Scientific and Educational Center of Lomonosov Moscow State University</institution></aff><aff><institution xml:lang="ru">МГУ им. М.В. Ломоносова</institution></aff></aff-alternatives><aff-alternatives id="aff5"><aff><institution xml:lang="en">Medical Scientific and Educational Center of Lomonosov Moscow State University</institution></aff><aff><institution xml:lang="ru">Медицинский научнообразовательный центр МГУ им. М.В. Ломоносова</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2019-02-15" publication-format="electronic"><day>15</day><month>02</month><year>2019</year></pub-date><issue>1</issue><issue-title xml:lang="en">NO1 (2019)</issue-title><issue-title xml:lang="ru">№1 (2019)</issue-title><fpage>114</fpage><lpage>118</lpage><history><date date-type="received" iso-8601-date="2023-02-27"><day>27</day><month>02</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2019, Bionika Media</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2019, ООО «Бионика Медиа»</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="en">Bionika Media</copyright-holder><copyright-holder xml:lang="ru">ООО «Бионика Медиа»</copyright-holder></permissions><self-uri xlink:href="https://journals.eco-vector.com/1728-2985/article/view/296468">https://journals.eco-vector.com/1728-2985/article/view/296468</self-uri><abstract xml:lang="en"><p>Obesity is one of the actual problems of modern medicine. The comorbid conditions in patients with obesity and metabolic syndrome have no less important value, attracting the attention of scientists and clinicians. Renal stone disease is one these diseases. We are interested in its development, which is directly related to the effect of excess amounts of such a monosaccharide, as fructose. For quite a long time, this carbohydrate was considered to have only positive properties, including its role in carbohydrate metabolism in general, and, in particular, in diabetes mellitus. Over the years, a pathological effect of excess fructose was detected. Since fructose was used to replace glucose, and accordingly, its amount in food, and especially in diabetic foods, was growing. In addition, the industrial production of corn-based fructose has become much less expensive than the production of sucrose, which has also contributed to the increased use of this monosaccharide in the food industry. In this article, the mechanisms leading to the development of pathologies which are associated with the excessive use of fructose, increase in the level of uric acid with subsequent formation of uric acid stones, are reviewed. Thus, the study of the effect of fructose on the pathogenesis of renal stone disease is interesting and extremely relevant, since for many specialists, it is animal protein that is associated with the development of kidney stone disease and the role of fructose is not only unobvious, but is also a revelation.</p></abstract><trans-abstract xml:lang="ru"><p>Одной из актуальных проблем современной медицины является ожирение. Коморбидные состояния, сопровождающие ожирение и метаболический синдром, являются не менее важной проблемой, привлекающей внимание ученых и практикующих врачей. Почечнокаменная болезнь - одно из таких заболеваний. Нас интересует аспект его развития, напрямую связанный с влиянием избыточного количества такого моносахарида, как фруктоза. Довольно долго этому углеводу присваивали только положительные свойства, в том числе в отношении углеводного обмена в целом и сахарного диабета в частности. Спустя годы было обнаружено патологическое воздействие избыточного количества фруктозы, а именно фруктозой пытались заменить глюкозу, и соответственно, ее количество в продуктах питания, прежде всего в продуктах для больных диабетом, росло. Кроме того, промышленное производство фруктозы на основе кукурузы стало значительно дешевле, чем таковое сахарозы, что также способствовало увеличению использования этого моносахарида в пищевой промышленности. В данной работе представлены механизмы, приводящие к развитию патологий от избыточного употребления фруктозы с последующим повышением уровня мочевой кислоты и формированием камней на ее основе. Изучение влияния фруктозы на патогенез почечнокаменной болезни интересно и крайне актуально, так как для многих специалистов с развитием почечнокаменной болезни ассоциируется именно мясо и роль фруктозы не только не очевидна, но и служит откровением.</p></trans-abstract><kwd-group xml:lang="en"><kwd>fructose</kwd><kwd>uric acid</kwd><kwd>kidney stones</kwd><kwd>fructokinase</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>фруктоза</kwd><kwd>мочевая кислота</kwd><kwd>камни в почках</kwd><kwd>фруктокиназа</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Romero V., Akpinar H., Assimos D.G. Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol. 2010;12(2-3):e86-96.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Khan S.R. Nephrocalcinosis in animal models with and without stones. Urol Res. 2010;38(6):429-38. Doi: 10.1007/s00240-010-0303-4.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Hall P.M. Nephrolithiasis: treatment, causes, and prevention. Cleve Clin J Med. 2009;76(10):583-91. Doi: 10.3949/ccjm.76a.09043.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Wong Y., Cook P., Roderick P., Somani B.K. Metabolic Syndrome and Kidney Stone Disease: A Systematic Review of Literature. J Endourol. 2016;30(3):246-53. Doi: 10.1089/end.2015.0567.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Rozhkova T.A., Ameliushkina V.A., Iarovaia E.B., Kotkina T.I., Malusheva P.P., Titov V.N. The hyperuricosuria in patients with high content of triglycerides: the combination of genetic and environmental factors and tactics of treatment. Klin Lab Diagn. 2012;6:3-8.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Abdelmalek M.F., Suzuki A., Guy C., Unalp-Arida A., Colvin R., Johnson R.J., Diehl A.M. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology. 2010;51(6):1961-71. Doi: 10.1002/hep.23535.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Vos M.B., Lavine J.E. Dietary fructose in nonalcoholic fatty liver disease. Hepatology. 2013;57(6):2525-31. Doi: 10.1002/hep.26299.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Wu X.W., Lee C.C., Muzny D.M., Caskey C.T. Urate oxidase: primary structure and evolutionary implications. Proc Natl Acad Sci USA. 1989;86(23):9412-9416.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Huang W., Deng Y., He Y. Visual colorimetric sensor array for discrimination of antioxidants in serum using MnO2 nanosheets triggered multicolor chromogenic system. Biosens Bioelectron. 2017;91:89-94. Doi: 10.1016/j. bios.2016.12.028.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Martillo M.A., Nazzal L., Crittenden D.B. The crystallization of monosodium urate. Curr Rheumatol Rep. 2014;16(2):400. Doi: 10.1007/s11926-013-0400-9.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Jin M., Yang F., Yang I., Yin Y., Luo J.J., Wang H., Yang X.F. Uric acid, hyperuricemia and vascular diseases. Front Biosci (Landmark Ed). 2012;17:656-669.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Daudon M., Frochot V. Crystalluria. Clin Chem Lab Med. 2015;53(Suppl. 2):s1479-87. Doi: 10.1515/cclm-2015-0860.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Halperin M.L., Cheema Dhadli S., Kamel K.S. Physiology of acid-base balance: links with kidney stone prevention. Semin Nephrol. 2006;26(6):441-46. Doi: 10.1016/j.semnephrol.2006.10.001.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Walter F., et al. Medical Physiology: A Cellular And Molecular Approaoch. Elsevier/Saunders, 2005. P. 852.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Nagami G.T. Luminal secretion of ammonia in the mouse proximal tubule perfused in vitro. J Clin Invest. 1988;81(1):159-164. Doi: 10.1172/ jci113287.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Klisic J., Hu M.C., Nief V., Reyes L., Fuster D., Moe O.W., Ambuhl P.M. Insulin activates Na(+)/H(+) exchanger 3: biphasic response and glucocorticoid dependence. Am J Physiol Renal Physiol. 2002;283(3):F532-9. Doi: 10.1152/ajprenal.00365.2001.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Johnson R.J., Segal M.S., Sautin Y., Nakagawa T., Feig D.I., Kang D.H., Gersch M.S., Benner S., Sanchez-Lozada L.G. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am J Clin Nutr. 2007;86(4):899-906. Doi: 10.1093/ajcn/86.4.899.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Bray G.A. Energy and fructose from beverages sweetened with sugar or high-fructose corn syrup pose a health risk for some people. Adv Nutr. 2013;4(2):220-25. Doi: 10.3945/an.112.002816.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Douard, V. and R.P. Ferraris, The role of fructose transporters in diseases linked to excessive fructose intake. J Physiol, 2013. 591(2). P. 401-414. Doi: 10.1113/jphysiol.2011.215731.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Karim S., Adams D.H., Lalor P.F. Hepatic expression and cellular distribution of the glucose transporter family. World J Gastroenterol. 2012;18(46):6771-6781. Doi: 10.3748/wjg.v18.i46.6771.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Teff K.L., Grudziak J., Townsend R.R., Dunn T.N., Grant R.W., Adams S.H., Keim N.L., Cummings B.P., Stanhope K.L., Havel P.J. Endocrine and metabolic effects of consuming fructose- and glucose-sweetened beverages with meals in obese men and women: influence of insulin resistance on plasma triglyceride responses. J Clin Endocrinol Metab. 2009;94(5):1562- 1569. Doi: 10.1210/jc.2008-2192.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>van den Berghe G., Bronfman M., Vanneste R., Hers H.G. The mechanism of adenosine triphosphate depletion in the liver after a load of fructose. A kinetic study of liver adenylate deaminase. Biochem J. 1977; 162(3):601-669.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Bais R., James H.M., Rofe A.M., Conyers R.A. The purification and properties of human liver ketohexokinase. A role for ketohexokinase and fructose-bisphosphate aldolase in the metabolic production of oxalate from xylitol. Biochem J. 1985;230(1):53-60.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Le M.T., Frye R.F., Rivard C.J., Cheng J., McFann K.K., Segal M.S., Johnson R.J., Johnson J.A. Effects of high-fructose corn syrup and sucrose on the pharmacokinetics of fructose and acute metabolic and hemodynamic responses in healthy subjects. Metabolism. 2012;61(5):641-651. Doi: 10.1016/j.metabol.2011.09.013.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Lin W.T., Chan T.F., Huang H.L., Lee C.Y., Tsai S., Wu P.W., Yang Y.C., Wang T.N., Lee C.H. Fructose-Rich Beverage Intake and Central Adiposity, Uric Acid, and Pediatric Insulin Resistance. J Pediatr. 2016;171:90-96.e1. Doi: 10.1016/j.jpeds.2015.12.061.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Carran E.L., White S.J., Reynolds A.N., Haszard J.J., Venn B.J. Acute effect of fructose intake from sugar-sweetened beverages on plasma uric acid: a randomised controlled trial. Eur J Clin Nutr. 2016;70(9):1034-1038. Doi: 10.1038/ejcn.2016.112.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Raivio K.O., Becker A., Meyer L.J., Greene M.L., Nuki G., Seegmiller J.E. Stimulation of human purine synthesis de novo by fructose infusion. Metabolism. 1975;24(7):861-869.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Yan L.J. Redox imbalance stress in diabetes mellitus: Role of the polyol pathway. Animal Model Exp Med. 2018;1(1):7-13. Doi: 10.1002/ ame2.12001.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Lorenzi M. The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient. Exp Diabetes Res. 2007;2007:61038. Doi: 10.1155/2007/61038.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Tsugawa T., Shinohara R., Nagasaka A., Nakano I., Takeda F., Nagata M., Oda N., Sawai Y., Hayakawa N., Suzuki A., Itoh M. Alteration of urinary sorbitol excretion in WBN-kob diabetic rats - treatment with an aldose reductase inhibitor. J Endocrinol. 2004;181(3):429-435.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Gabbay K.H. The sorbitol pathway and the complications of diabetes. N Engl J Med. 1973;288(16):831-836. Doi: 10.1056/nejm197304192881609.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Choi Y.J., Yoon Y., Lee K.Y., Hien T.T., Kang K.W., Kim K.C., Lee J., Lee M.Y., Lee S.M., Kang D.H., Lee B.H. Uric acid induces endothelial dysfunction by vascular insulin resistance associated with the impairment of nitric oxide synthesis.Faseb J. 2014;28(7):3197-31204. Doi: 10.1096/ fj.13-247148.</mixed-citation></ref></ref-list></back></article>
